Digitek Recall: Generic drug maker reaps benefits of Digitek recall

Generic drug maker reaps benefits of Digitek recall

October 7th, 2008 by Emily Marsh

Many previous Digitek consumers have steered away from Digitek after the recall. However, as Digitek has lost consumers, Lannett Company has only reaped the benefits.

Sales for Lannett’s digoxin, a generic form of Digitek, still have been strong since the recall of Digitek in April of this year.

Because digoxin was not recalled, this company has been able to maintain a good financial report for the fourth quarter of the fiscal 2008 year. Especially after the Digitek recall, the company continues to work with the FDA to guarantee a safe and immense supply of this product.

Established in 1942, Lannett Company, distributing generic products for various symptoms, is a popular leader in the pharmaceutical industry. Lanett sells its products to drug wholesalers, retail drug chains, repackagers, distributors, and government agencies.

Digoxin has proven to be a safe and popular alternative to the recalled Digitek.

Tags: Digitek, Digitek recall, Digoxin, FDA, Lannett Company

This entry was posted on Tuesday, October 7th, 2008 at 8:23 am and is filed under Digitek recall, News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.